antimycin a has been researched along with atovaquone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Clardy, J; Dong, CK; Duraisingh, MT; Dvorin, JD; Patel, V; Wirth, DF; Yang, JC | 1 |
| Biagini, GA; Chandramohanadas, R; Darling, C; DeGrado, WF; Diamond, SL; Fisher, N; Greenbaum, DC; Jing, H; Jo, H; Lucumi, E; Napper, AD; Shone, AE; Ward, SA | 1 |
| Clardy, J; Derbyshire, ER; Mota, MM; Prudêncio, M | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Srivastava, IK; Vaidya, AB | 1 |
| Abdala-Valencia, H; Basselin, M; Hunt, SM; Kaneshiro, ES | 1 |
| Arumugam, R; Nagaraj, VA; Padmanaban, G; Prasad, D; Rangarajan, PN | 1 |
7 other study(ies) available for antimycin a and atovaquone
| Article | Year |
|---|---|
Type II NADH dehydrogenase of the respiratory chain of Plasmodium falciparum and its inhibitors.
Topics: Animals; Biphenyl Compounds; Chemistry, Pharmaceutical; Dihydroorotate Dehydrogenase; Drug Design; Electron Transport; Electrons; Enzyme Inhibitors; Indophenol; Models, Chemical; NADH Dehydrogenase; Onium Compounds; Oxidoreductases Acting on CH-CH Group Donors; Phenol; Plasmodium falciparum; Quinolones; Vitamin K 3 | 2009 |
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
Topics: Animals; Antimalarials; Drug Resistance, Multiple; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum | 2010 |
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
A mechanism for the synergistic antimalarial action of atovaquone and proguanil.
Topics: Animals; Antimalarials; Antimycin A; Atovaquone; Drug Synergism; Female; Folic Acid Antagonists; Male; Membrane Potentials; Mice; Mice, Inbred BALB C; Mitochondria; Naphthoquinones; Oxygen Consumption; Plasmodium yoelii; Proguanil | 1999 |
Ubiquinone synthesis in mitochondrial and microsomal subcellular fractions of Pneumocystis spp.: differential sensitivities to atovaquone.
Topics: Animals; Antimycin A; Atovaquone; Benzphetamine; Coenzymes; Dicyclohexylcarbodiimide; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Hydrogen-Ion Concentration; Kinetics; Microscopy, Fluorescence; Microsomes; Mitochondria; Naphthoquinones; Pneumocystis; Rats; Sensitivity and Specificity; Subcellular Fractions; Temperature; Time Factors; Ubiquinone | 2005 |
Protoporphyrinogen IX oxidase from Plasmodium falciparum is anaerobic and is localized to the mitochondrion.
Topics: Anaerobiosis; Antimycin A; Antiprotozoal Agents; Atovaquone; Cloning, Molecular; Electron Transport; Gene Expression; Microscopy, Fluorescence; Mitochondria; Mitochondrial Proteins; Plasmodium falciparum; Protoporphyrinogen Oxidase; Protozoan Proteins | 2010 |